Peng Xia
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 1%
- Long-Term Effects of COVID-19
Papers in
- Hepatology 16
- Liver physiology and pathology 16
-
- PI3K/AKT/mTOR signaling in cancer 11
- RNA modifications and cancer 10
- Protein Kinase Regulation and GTPase Signaling 7
- Extracellular vesicles in disease 7
- Co-authors
- Jing Ai (31 shared papers)Hao Zhang (10 shared papers)Yufeng Yuan (12 shared papers)Meiyu Geng (23 shared papers)Weijie Ma (7 shared papers)Kequan Xu (6 shared papers)Zhaokang Cheng (6 shared papers)Yuening Liu (5 shared papers)
- Journals
- European Journal of Medicinal Chemistry (6 papers)Journal of Medicinal Chemistry (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Computational and Applied Mathematics (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Peng Xia
157 papers receiving 5.3k citations
Peng Xia's Hit Papers
Peers
Comparison fields: 5 of 165
- Infectious Diseases 1.5k
- Neurology 938
- Internal Medicine 184
- Dermatology 238
- Cancer Research 371
Countries citing papers authored by Peng Xia
This map shows the geographic impact of Peng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Xia more than expected).
Fields of papers citing papers by Peng Xia
This network shows the impact of papers produced by Peng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Xia. The network helps show where Peng Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19 Hit paper breakdown → | 2020 | 1714 |
| 2 | 2020 | 484 | |
| 3 | 2003 | 194 | |
| 4 | 2021 | 182 | |
| 5 | 2020 | 148 | |
| 6 | 2023 | 130 | |
| 7 | 2020 | 104 | |
| 8 | 2014 | 94 | |
| 9 | 2017 | 85 | |
| 10 | 2016 | 80 | |
| 11 | 2022 | 74 | |
| 12 | 2020 | 73 | |
| 13 | 2001 | 69 | |
| 14 | 2017 | 64 | |
| 15 | 2020 | 63 | |
| 16 | 2011 | 56 | |
| 17 | 2021 | 49 | |
| 18 | P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells. | 2016 | 48 |
| 19 | 2018 | 48 | |
| 20 | 2018 | 46 |
About Peng Xia
Peng Xia is a scholar working on Hepatology, Molecular Biology, Cancer Research, Immunology and Oncology, having authored 165 papers that have together received 5.4k indexed citations. Recurring topics across this work include Liver physiology and pathology (16 papers), PI3K/AKT/mTOR signaling in cancer (11 papers), RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Extracellular vesicles in disease (7 papers), Immune cells in cancer (6 papers) and Mast cells and histamine (6 papers). The work is most often cited by research in Infectious Diseases (1.5k citations), Neurology (938 citations), Internal Medicine (184 citations), Dermatology (238 citations) and Cancer Research (371 citations). Peng Xia has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jing Ai, Hao Zhang, Yufeng Yuan, Meiyu Geng, Weijie Ma, Kequan Xu, Zhaokang Cheng, Yuening Liu, Jingrui Chen and Zhonglin Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Computational and Applied Mathematics and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.